Why the study?
COVID-19 mRNA vaccines have drawn attention due to advantages such as rapid development and flexibility, warranting a summary of current advances, challenges, and future directions.
Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Supports further COVID-19 vaccine development; leaves open questions on efficacy and durability in larger trials.
Fang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: